Award
National Institute of Allergy and Infectious Diseases PAR-21-083
Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial)
Recipient
Mayo Clinic Jacksonville
Award Amount
$2,832,926.00
Ceiling
$2,832,926.00
Awarded
May 07, 2026
Identifier
PAR-21-083
NIH grant awarded to Mayo Clinic Jacksonville for a clinical trial to improve cephalosporin allergy diagnostics, supporting drug allergy research.
Description
This is a high-risk clinical trial with mechanistic studies to optimize diagnostics for cephalosporin allergy. The project involves collaboration with drug allergy specialists and aims to determine the mechanisms and antigenic determinants of cephalosporin allergy. The project aligns with NIH/NIAID goals to advance drug allergy research.